Natural History Study of Serious Medical Events in PWS
NCT03718416 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 700
Last updated 2024-02-29
Summary
PATH for PWS is a study to help researchers better understand serious medical events in PWS over a 4-year period, as well as evaluate how PWS-related behaviors change over time. The data from this study is intended to inform the development and clinical trial design of potential new treatments.
Conditions
Sponsors & Collaborators
-
Prader-Willi Syndrome Association USA
collaborator OTHER -
Foundation for Prader-Willi Research Canada
collaborator UNKNOWN -
Prader-Willi Research Foundation Australia
collaborator UNKNOWN -
Prader-Willi Syndrome Association
collaborator OTHER -
Foundation for Prader-Willi Research
lead OTHER
Eligibility
- Min Age
- 5 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-09-28
- Primary Completion
- 2024-01-31
- Completion
- 2024-01-31
Countries
- United States
Study Locations
More Related Trials
-
A Study of CSTI-500 in Patients With Prader-Willi Syndrome
NCT07348601 ·Status: RECRUITING ·Phase: PHASE2
-
Tracking Neurodegeneration in Early Wolfram Syndrome
NCT02455414 ·Status: COMPLETED
-
The Hunger Elimination or Reduction Objective (HERO ) Open -Label Extension (OLE) Trial
NCT07197034 ·Status: SUSPENDED ·Phase: PHASE3
-
Open-Label Extension Study of DCCR in Patients With Prader-Willi Syndrome
NCT05701774 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Longitudinal Studies to Identify Biomarkers for Sturge-Weber Syndrome
NCT04717427 ·Status: RECRUITING
-
A 2-Part Study to Assess Efficacy, Safety and Tolerability of BMB-101 for the Treatment of Patients With Prader-Willi Syndrome.
NCT07266324 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Open-Label Extension Study of DCCR in PWS Followed by Double-Blind, Placebo-Controlled, Randomized Withdrawal Period
NCT03714373 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Oral ARD-101 in Patients With Prader-Willi Syndrome
NCT05153434 ·Status: COMPLETED ·Phase: PHASE2
-
Natural History Study of Patients With VCP-related Disease
NCT04823143 ·Status: COMPLETED
-
Study of Tesomet With Open-label Extension in Subjects With Prader-Willi Syndrome
NCT05198362 ·Status: WITHDRAWN ·Phase: PHASE2
-
Natural History Study of Participants With Sanfilippo Syndrome Type IIIC
NCT05825131 ·Status: RECRUITING
-
Efficacy and Safety Study of Protein C Concentrate in Subjects With Severe Congenital Protein C Deficiency
NCT00157118 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Angelman Syndrome Natural History Study
NCT04507997 ·Status: RECRUITING
-
A Long-Term Safety Study of PTC923 in Participants With Phenylketonuria
NCT05166161 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
STXBP1 and SYNGAP1 Related Disorders Natural History Study
NCT06555965 ·Status: RECRUITING
-
Angelman Syndrome Natural History Study-FAST UK
NCT05100810 ·Status: RECRUITING
-
Natural History Studies of Mucopolysaccharidosis III
NCT02037880 ·Status: COMPLETED
-
Pyruvate Kinase Deficiency Natural History Study
NCT02053480 ·Status: COMPLETED
-
Understanding the Role of Gut Microbiota in Hyperphagia in Prader-Willi Syndrome
NCT05541003 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Vatiquinone for the Treatment of Participants With Friedreich Ataxia
NCT05485987 ·Status: COMPLETED ·Phase: PHASE2
-
PWS Outcomes Assessment Study
NCT04102839 ·Status: COMPLETED
-
A Study to Assess the Safety and Efficacy of Vatiquinone in Participants With Friedreich Ataxia
NCT05515536 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Trial of Sirolimus for Cognitive Impairment in Sturge-Weber Syndrome
NCT03047980 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Phase 3, Multicenter, Open-Label Extension Study of Phenoptin in Subjects With PKU Who Have Elevated Phenylalanine Levels
NCT00225615 ·Status: COMPLETED ·Phase: PHASE3
-
Determine Range of Tissue Frataxin Concentrations and Other Potential Biomarkers
NCT05028764 ·Status: COMPLETED